The round was led by Tencent, followed by several other top investors in China.
The company intends to use the funds for the development of Digital Therapeutics (DTx) and building medical network to service insurance companies.
Led by Lu Yi, CEO, QTC Care focuses on introducing the world’s top medical resources to the Chinese market and utilizes artificial intelligence to streamline treatment recovery and disease prevention. The company has developed out-of-hospital patient health management platforms for lung cancer patients and breast cancer patients Another “Cancer patients’ family members” assistance and care project is also up and running to provide guidance to family members in cancer patients’ care.
QTC Care core team has been concentrating on bringing high quality oncology medical resources to China since 2013, and has independently developed the remote video consultation system. Now, it boasts resources of cooperation with more than 600 internationally renowned hospitals and connections with thousands of world top doctors.